Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Galati

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Future Oncology (London, England)|January 19, 2016
The calm before the storm: a report from the International Liver Cancer Association Congress 2015--part 1Giuseppe Cabibbo, Maria Reig, Gennaro Gadaleta-Caldarola, et al.
European Journal of Clinical Investigation|September 8, 2022
The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinomaQuirino Lai, Nicoletta De Matthaeis, Michele Finotti, et al.
World Journal of Hepatology|August 1, 2025
Autoimmune hepatitis with syncytial giant cells in chronic lymphocytic leukemia: A case report and literature reviewMarta Giacomelli, Simone Carotti, Federico Vozella, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 7, 2016
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patientsAntonio De Vincentis, Giorgio Pennazza, Marco Santonico, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 30, 2010
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infectionUmberto Vespasiani-Gentilucci, Giovanni Galati, Chiara Mazzarelli, et al.
Scientific Reports|May 6, 2016
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept studyAntonio De Vincentis, Giorgio Pennazza, Marco Santonico, et al.
Internal Medicine (Tokyo, Japan)|November 5, 2008
Peripheral graft infection due to Staphylococcus aureus without abnormal findings by 99mTc-HMPAO-labeled-leukocyte scanEnrica Fiori, Umberto Vespasiani Gentilucci, Maria Francisca Navajas, et al.
Archives of Medical Science : AMS|April 5, 2014
Haemorrhoidal disease in severe portal hypertension: a combined approach with transjugular intrahepatic portosystemic shunt (TIPS) and transanal haemorrhoidal dearterialization (THD)Giovanni Galati, Antonio De Vincentis, Valter Ripetti, et al.
Current Drug Metabolism|September 22, 2020
Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver CirrhosisGiovanni Galati, Antonio Fabio Massimo Vainieri, Claudia Angela Maria Fulgenzi, et al.
European Journal of Gastroenterology & Hepatology|February 13, 2009
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutationGiovanni Galati, Umberto Vespasiani Gentilucci, Ilaria Sansoni, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Future Oncology (London, England)|January 19, 2016
The calm before the storm: a report from the International Liver Cancer Association Congress 2015--part 1Giuseppe Cabibbo, Maria Reig, Gennaro Gadaleta-Caldarola, et al.
European Journal of Clinical Investigation|September 8, 2022
The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinomaQuirino Lai, Nicoletta De Matthaeis, Michele Finotti, et al.
World Journal of Hepatology|August 1, 2025
Autoimmune hepatitis with syncytial giant cells in chronic lymphocytic leukemia: A case report and literature reviewMarta Giacomelli, Simone Carotti, Federico Vozella, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 7, 2016
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patientsAntonio De Vincentis, Giorgio Pennazza, Marco Santonico, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 30, 2010
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infectionUmberto Vespasiani-Gentilucci, Giovanni Galati, Chiara Mazzarelli, et al.
Scientific Reports|May 6, 2016
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept studyAntonio De Vincentis, Giorgio Pennazza, Marco Santonico, et al.
Internal Medicine (Tokyo, Japan)|November 5, 2008
Peripheral graft infection due to Staphylococcus aureus without abnormal findings by 99mTc-HMPAO-labeled-leukocyte scanEnrica Fiori, Umberto Vespasiani Gentilucci, Maria Francisca Navajas, et al.
Archives of Medical Science : AMS|April 5, 2014
Haemorrhoidal disease in severe portal hypertension: a combined approach with transjugular intrahepatic portosystemic shunt (TIPS) and transanal haemorrhoidal dearterialization (THD)Giovanni Galati, Antonio De Vincentis, Valter Ripetti, et al.
Current Drug Metabolism|September 22, 2020
Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver CirrhosisGiovanni Galati, Antonio Fabio Massimo Vainieri, Claudia Angela Maria Fulgenzi, et al.
European Journal of Gastroenterology & Hepatology|February 13, 2009
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutationGiovanni Galati, Umberto Vespasiani Gentilucci, Ilaria Sansoni, et al.
Pageof 5